FDA Proposes Boxed Warning on Breast Implant Risks

Share this post

In draft guidance issued today, the FDA proposes labeling changes to ensure that women receive and understand information regarding the benefits and risks of these devices.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply